Cite
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database
MLA
Voso, Maria Teresa, et al. Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1105014611&authtype=sso&custid=ns315887.
APA
Voso, M. T., Fenu, S., Latagliata, R., Buccisano, F., Piciocchi, A., Aloe Spiriti, M., Breccia, M., Criscuolo, M., Andriani, A., Mancini, S., Niscola, P., Naso, V., Nobile, C., Piccioni, A., D’Andrea, M., D’Addosio, A., Leone, G., & Venditti, A. (2013). Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.
Chicago
Voso, Maria Teresa, S Fenu, R Latagliata, F Buccisano, A Piciocchi, Ma Aloe Spiriti, M Breccia, et al. 2013. “Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1105014611&authtype=sso&custid=ns315887.